Evidence map›Paper›PMID 26797318›Full record

Trial reportJournal of child and adolescent psychopharmacology2016

Caregiver Satisfaction with a Multisite Trial of Atomoxetine and Parent Training for Attention-Deficit/Hyperactivity Disorder and Behavioral Noncompliance in Children with Autism Spectrum Disorder.

Jill A Hollway, Michael G Aman, Marissa I Mendoza-Burcham, Laura Silverman, L Eugene Arnold, Rameshwari Tumuluru, Benjamin L Handen, Luc Lecavalier, Kristin Page, Pamela Sayre and 1 more

Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of child and adolescent psychopharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jill A Hollway1 The Nisonger Center, University Center for Excellence in Development Disabilities (UCEDD), Ohio State University , Columbus, Ohio.
Michael G Aman1 The Nisonger Center, University Center for Excellence in Development Disabilities (UCEDD), Ohio State University , Columbus, Ohio.
Marissa I Mendoza-Burcham2 Department of Psychiatry at the Western Psychiatric Institute and Clinic, University of Pittsburgh , Pittsburgh, Pennsylvania.
Laura Silverman3 Division of Neurodevelopmental and Behavioral Pediatrics at the University of Rochester , Rochester, New York.
L Eugene Arnold1 The Nisonger Center, University Center for Excellence in Development Disabilities (UCEDD), Ohio State University , Columbus, Ohio.
Rameshwari Tumuluru2 Department of Psychiatry at the Western Psychiatric Institute and Clinic, University of Pittsburgh , Pittsburgh, Pennsylvania.
Benjamin L Handen2 Department of Psychiatry at the Western Psychiatric Institute and Clinic, University of Pittsburgh , Pittsburgh, Pennsylvania.
Luc Lecavalier1 The Nisonger Center, University Center for Excellence in Development Disabilities (UCEDD), Ohio State University , Columbus, Ohio.
Kristin Page1 The Nisonger Center, University Center for Excellence in Development Disabilities (UCEDD), Ohio State University , Columbus, Ohio.
Pamela Sayre1 The Nisonger Center, University Center for Excellence in Development Disabilities (UCEDD), Ohio State University , Columbus, Ohio.
Tristram Smith3 Division of Neurodevelopmental and Behavioral Pediatrics at the University of Rochester , Rochester, New York.

Funding

UNIVERSITY OF ROCHESTER'S RESEARCH ASSOCIATE ORGANIZATIONUL1RR024160 · NCRR · UNIVERSITY OF ROCHESTER · PI PEARSON, THOMAS ARTHUR · 2006 to 2011
$38.7M
The Ohio State University Center for clinical and Translational ScienceUL1TR001070 · NCATS · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2013 to 2017
$22.6M
3/3-Atomoxetine Placebo and Parent Training in AutismR01MH083247 · NIMH · UNIVERSITY OF ROCHESTER · PI SMITH, TRISTRAM H · 2008 to 2012
$1.4M
NCATS NIH HHS UL1 TR001070NCRR NIH HHS UL1 RR024160NIMH NIH HHS R01 MH083247
6 · The paper itself

Abstract

objectiveThe purpose of this study was to examine caregiver satisfaction with the research experience in a randomized clinical trial of atomoxetine (ATX) and parent training (PT) for attention-deficit/hyperactivity disorder (ADHD) and behavioral noncompliance co-occurring with autism.

methodsThe Children with Hyperactivity and Autism Research Treatment Study (CHARTS) randomly assigned 128 children 5.00-14.11 years of age to four treatment groups (ATX + PT, ATX alone, PT + placebo[PBO], and PBO). Caregivers completed an 18 item questionnaire about their satisfaction with the research experience. We summarized caregiver responses with descriptive statistics and examined whether the responses were associated with demographic variables, treatment assignment, or the child's response to treatment (positive or negative).

resultsNinety-three percent of caregivers (119) completed the questionnaire. When asked if they would join the study again if given the chance, 87% (103) responded "yes," 13% (15) responded "maybe," and 1% (1) responded "no." When asked if they would recommend the study to other caregivers of children with similar problems, 92% (109) responded "yes" and 8% responded (10) "maybe." Of the 59 Parent Satisfaction Questionnaire (PSQ) respondents who received PT, 75% (44) felt more confident in managing current child behaviors, 24% (14) felt that their level of confidence was unchanged, and 2% (1) felt less confident. Most caregivers expressed satisfaction with the study procedures, including the number of visits and the safety monitoring protocols.

conclusionsIn general, caregivers were highly satisfied with their research experience. These findings may be useful for informing human subject committees and for designing study protocols that are appealing to families.

Indexed as

AdolescentAtomoxetine HydrochlorideAttention Deficit Disorder with HyperactivityAutism Spectrum DisorderCaregiversChildCombined Modality TherapyFemaleHumansMaleParentsPersonal SatisfactionSurveys and QuestionnairesTreatment OutcomeAtomoxetine Hydrochlorideatomoxetineautism spectrum disorderparent trainingsatisfaction

Identifiers

PMID26797318
PMCPMC5116688

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.